Director, Market Insights

About Us

We are a global, family-owned company driven by a passion for innovation. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.

With 700+ employees across the UK, Ireland, the Nordics, Germany, the USA, and China, we are committed to scientific excellence, patient care, and collaborative partnerships with the medical community.

Our core values define who we are:

• People-Driven – We are a family-held company built on passionate, knowledgeable people. We value integrity, open-mindedness and respect and are guided by these values in all our endeavors. We respect each individual who becomes a part of our journey, from our employees and partners to our end-users. And we recognize that the strength in all our collaborations is trust.
• Committed to Quality – Quality is our source of inspiration. Quality drives our results. It represents our aspiration for excellence and our focus on driving continual improvements. For our partners and end-users, quality must always be tangible in our products, processes and people. This way, quality is the promise we keep every day.
• Innovating for Better Lives – Innovation is essential in our quest to improve the lives of humans. We seek to address unmet needs through our expertise in iron and carbohydrate-based pharmaceuticals. We believe in a holistic and collaborative approach to research and innovation, so we work together with the scientific and medical communities to set new standards.

We have continued our growth trajectory since we launched our first product in the US, Monoferric® (ferric derisomaltose), through acquisitions, partnerships, and pipeline. Our R&D investments continue to leverage our core competencies, alongside our recent advancements in oncology supportive care.

Join us in shaping the future of patient care through innovation and collaboration.

The Associate Director, Market Insights leads commercial analytics, market insights, forecasting, and competitive intelligence for Pharmacosmos Therapeutics. This role translates market dynamics, customer behavior, patient trends, competitive developments, and business performance data into actionable insights that inform brand strategy, commercial execution, lifecycle planning, and senior leadership decision-making.

The role also advances the organization’s analytics capabilities, including patient finding, opportunity identification, alerts, customer prioritization, market research, forecasting, and performance measurement, while managing and developing the Manager, Market Insights.

• Lead analysis of brand performance, market trends, customer behavior, patient dynamics, payer influences, and business drivers to identify risks, opportunities, and actionable recommendations.
• Develop and enhance patient-finding, opportunity identification, customer prioritization, and alert-based analytics to support more targeted commercial execution.
• Oversee dashboards, reports, alerts, and ad hoc analyses used by Commercial, Marketing, Market Access, Medical, Finance, and senior leadership.
• Conduct secondary data and behavioral analyses of HCPs, accounts, patients, and payers to understand business performance, referral dynamics, source of business, account opportunity, and customer prioritization.
• Lead forecasting activities, including product forecasts, assumptions, scenario planning, sensitivity analyses, and communication of key forecast drivers.
• Evaluate and integrate available data sources, including claims, sales, financial data, market research, syndicated market data, account-level data, patient data, and other third-party data assets.
• Lead market research and insight generation to assess brand performance, customer perceptions, market barriers, patient access dynamics, and emerging opportunities.
• Develop and manage an inline competitive intelligence process for marketed products, including monitoring competitor strategy, market events, pricing and access dynamics, clinical developments, promotional activity, and potential disruptive…